Nobel Biocare Holding AG (Nobel Biocare Holding AG) ROCE % : 13.94% (As of Dec. 2013)

View and export this data going back to . Start your Free Trial

What is Nobel Biocare Holding AG ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Nobel Biocare Holding AG's annualized ROCE % for the quarter that ended in Dec. 2013 was 13.94%.

Nobel Biocare Holding AG ROCE % Historical Data

The historical data trend for Nobel Biocare Holding AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nobel Biocare Holding AG ROCE % Chart

Nobel Biocare Holding AG Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

ROCE %

Get a 7-Day Free Trial

28.46

22.19

17.98

15.64

13.94

Nobel Biocare Holding AG Semi-Annual Data
	Dec02	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13
ROCE %	Get a 7-Day Free Trial							28.46	22.19	17.98	15.64	13.94

Nobel Biocare Holding AG ROCE % Calculation

Nobel Biocare Holding AG's annualized ROCE % for the fiscal year that ended in Dec. 2013 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2013 )		(A: Dec. 2012 )		(A: Dec. 2013 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2013 )		(A: Dec. 2012 )		(A: Dec. 2013 )
	=	87.701	/	( ( (788.762 - 177.131)	+	(835.514 - 188.751) )	/ 2 )
	=	87.701	/	( (611.631	+	646.763)	/ 2 )
	=	87.701	/	629.197
	=	13.94 %

Nobel Biocare Holding AG's ROCE % of for the quarter that ended in Dec. 2013 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2013 )		(Q: Dec. 2012 )		(Q: Dec. 2013 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2013 )		(Q: Dec. 2012 )		(Q: Dec. 2013 )
	=	87.701	/	( ( (788.762 - 177.131)	+	(835.514 - 188.751) )	/ 2 )
	=	87.701	/	( ( 611.631	+	646.763 )	/ 2 )
	=	87.701	/	629.197
	=	13.94 %

(1) Note: The EBIT data used here is one times the annual (Dec. 2013) EBIT data.

Nobel Biocare Holding AG (OTCPK:NBHGF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Nobel Biocare Holding AG ROCE % Related Terms

Thank you for viewing the detailed overview of Nobel Biocare Holding AG's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nobel Biocare Holding AG (OTCPK:NBHGF) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.nobelbiocare.com

Nobel Biocare Holding AG was founded in 2002 in Zurich,Switzerland. The Company offers dental implant systems, high-precision individualized prosthetics and CAD/CAM systems, diagnostics, treatment planning, guided surgery solutions and biomaterials. Its segments include Implant system products and Individualized products. Its geographical segments include United States, Japan, Switzerland, and Other Countries.

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Headlines

From GuruFocus

The new NobelProcera� Zirconia Implant Bridge simplifies the partnership between clinicians and technicians

By PRNewswire PRNewswire • 02-08-2021

Mario Gabelli Comments on Nobel Biocare Holding AG

By Vera Yuan Vera Yuan • 10-28-2014